Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 1/20 | 0.43 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.43 |
| ▸ | ACACA | Q13085 | 3/20 | 0.42 |
| ▸ | ACACB | O00763 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19291653 | 0.98 | CARM1 (0.43) | CARM1PRMT6ACACAACACB | |
| SCHEMBL19291785 | 0.98 | CARM1 (0.43) | CARM1PRMT6ACACAACACB | |
| SCHEMBL19291575 | 0.96 | SIRT2 (0.43) | CARM1PRMT6 | |
| SCHEMBL25819681 | 0.96 | SIRT2 (0.43) | CARM1PRMT6 | |
| SCHEMBL19291875 | 0.96 | SIRT2 (0.43) | CARM1PRMT6 | |
| SCHEMBL2206380 | 0.96 | SIRT2 (0.43) | CARM1PRMT6 | |
| SCHEMBL19291555 | 0.96 | SIRT2 (0.43) | CARM1PRMT6 | |
| SCHEMBL22700926 | 0.91 | SIRT2 (0.42) | CARM1PRMT6 | |
| SCHEMBL16030334 | 0.90 | CARM1 (0.41) | CARM1PRMT6ACACAACACB | |
| SCHEMBL25826801 | 0.88 | CARM1 (0.40) | CARM1PRMT6ACACAACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218549-A1 | ALKOXY COMPOUNDS FOR DISEASE TREATMENT | ACUCELA INC. | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230218549-A1 | ALKOXY COMPOUNDS FOR DISEASE TREATMENT | ALDH1A2, CLN6, AGER | CARM1 3318/4885PRMT6 3578/4885ACACA 236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.